Contract facts
FederalOIMT COST ALLOCATION AND TECHNOLOGY BUSINESS MANAGEMENT is a federal award for Fda Office Of Acq Grant Svcs held by Deloitte Consulting LLP. Estimated value $98.1M ($98.1M obligated). Current period of performance ends Sep 28, 2027. Last award drew 1 bidder. Place of performance: SILVER SPRING, MD. Related solicitation 75F40122Q00004.
OIMT COST ALLOCATION AND TECHNOLOGY BUSINESS MANAGEMENT
Recompete timing
PublicCurrent PoP ends Sep 28, 2027 (404 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Incumbent footprint
Public recordDeloitte Consulting LLP — $8.7B obligated across 1,463 awards (firm-wide, all agencies) · lead buyer General Services Administration (GSA).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40122F19002?
75F40122F19002 (OIMT COST allocation and technology business) is a Fda Office Of Acq Grant Svcs award with an estimated value of $98.1M, currently held by Deloitte Consulting LLP. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40122F19002?
Fda Office Of Acq Grant Svcs awarded 75F40122F19002 to Deloitte Consulting LLP.
Who is the incumbent on 75F40122F19002?
Deloitte Consulting LLP is the incumbent with $8.7B across 1463 related awards in SCOUT’s public footprint. The current period of performance ends Sep 28, 2027.
When does Deloitte Consulting LLP’s 75F40122F19002 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 28, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.